Search

Your search keyword '"Lucía Márquez"' showing total 73 results

Search Constraints

Start Over You searched for: Author "Lucía Márquez" Remove constraint Author: "Lucía Márquez" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
73 results on '"Lucía Márquez"'

Search Results

1. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

2. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

3. Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease

4. Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis

5. Age-Related microRNA Overexpression in Lafora Disease Male Mice Provides Links between Neuroinflammation and Oxidative Stress

6. The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn’s Disease

7. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

8. De Vox a Ana Rosa (y viceversa): el fenómeno de la «okupación» en los programas de infoentretenimiento.

10. Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU

11. Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry

12. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

13. OP29 Tofacitinib in ulcerative colitis: Real-world evidence from Eneida Registry

14. Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry

15. Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry

16. Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

17. Investigar a la intemperie: reflexiones sobre métodos desde las ciencias sociales en el oficio

18. Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry

19. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry

20. Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease

21. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study

22. Neuroprotective Effect of Hydroxytyrosol in Experimental Diabetic Retinopathy: Relationship with Cardiovascular Biomarkers

23. DOP31 Management and outcome of postoperative Crohn’s Disease in the elderly as compared to young adults: Data from Eneida registry

24. P357 Long-term outcomes of biologic therapy in Crohn’s disease complicated with internal fistulizing disease: BIOSCOPE study from GETECCU

25. P262 Effectiveness and safety of ustekinumab in elderly patients: Real world evidence from ENEIDA registry

26. P774 Low adhesion to latent tuberculosis (TB) screening recommendations in inflammatory bowel disease (IBD) patients: Results of the INFEII registry of GETECCU

27. OP034 The initiation of thiopurines in elderly patients with inflammatory bowel disease is associated with an increased risk of adverse effects: a case–control study of the ENEIDA registry

28. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study

30. Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial

31. P671 Effect of genetic polymorphisms in the folate pathway on the efficacy and safety of methotrexate in Crohn’s disease

32. Su1038 INTRALESIONAL INJECTION OF ADALIMUMAB IN INTESTINAL STRICTURES OF PATIENTS WITH CROHN’S DISEASE: A RANDOMIZED, MULTICENTER, PROSPECTIVE CLINICAL TRIAL

33. Post-Operative Morbidity and Mortality of a Cohort of Steroid Refractory Acute Severe Ulcerative Colitis: Nationwide Multicenter Study of the GETECCU ENEIDA Registry

34. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD

35. P223 Efficacy and safety of tacrolimus in Crohn’s disease: a nationwide, multi-centric study from GETECCU

36. P439 Effectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the ENEIDA registry

37. Human Secretory IgM Emerges from Plasma Cells Clonally Related to Gut Memory B Cells and Targets Highly Diverse Commensals

38. P275 Clinical characteristics, associated malignancies and management of primary sclerosing colangitis in inflammatory bowel disease patients: A Spanish nationwide study based on the ENEIDA registry

39. Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry

40. P607 Post-operative mortality and predictive factors in a cohort of severe refractory ulcerative colitis patients from the ENEIDA Registry (1989–2013): a multicenter nationwide study

41. A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis

42. Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients

43. Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids

44. Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue

45. La Representación de Hugo Chávez en la Revista Memorias de Venezuela (2008-2012)

46. Sa1117 Extracolonic Neoplasias in Inflammatory Bowel Disease Patients: Data From the GETECCU Eneida Registry

47. Anti-allergic properties of Mangifera indica L. extract (Vimang) and contribution of its glucosylxanthone mangiferin

48. Tu1943a A Genome-Wide Association Study Identifies DSE-FAM26F As a Risk Locus for Ulcerative Colitis

49. Sa1223 Phenotypic Characteristics and Use of Therapeutic Resources in Elderly-Onset Inflammatory Bowel Disease: A Multicentre, Case-Control Study

50. P606 Phenotypic characteristics and use of therapeutic resources in elderly-onset inflammatory bowel disease: A multicentre, case-control study

Catalog

Books, media, physical & digital resources